0000899866-17-000157.txt : 20170830 0000899866-17-000157.hdr.sgml : 20170830 20170830181311 ACCESSION NUMBER: 0000899866-17-000157 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170828 FILED AS OF DATE: 20170830 DATE AS OF CHANGE: 20170830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Neill Julie CENTRAL INDEX KEY: 0001630299 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 171061640 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS STREET 2: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 COLLEGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 2032722596 MAIL ADDRESS: STREET 1: 100 COLLEGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 4 1 wf-form4_150413117771204.xml FORM 4 X0306 4 2017-08-28 0 0000899866 ALEXION PHARMACEUTICALS INC ALXN 0001630299 O'Neill Julie C/O ALEXION PHARMACEUTICALS, INC 100 COLLEGE STREET NEW HAVEN CT 06510 0 1 0 0 EVP. Global Operations Common Stock, par value $.0001 per share 2017-08-28 4 S 0 11160 140 D 26704 D The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act. /s/ Michael Greco, Attorney-in-Fact for Julie O'Neill 2017-08-30